Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use

Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use

US Patent 9278960 · Granted Mar 8, 2016

Estimated economic value: $114,032,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclopentapyrrole orexin receptor agonists2025
Tetrahydroquinazoline derivatives as selective cytotoxic agents2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors2025
Pyrrolidine orexin receptor agonists2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Pyrimidone derivatives as selective cytotoxic agents against HIV infected cells2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Tetracyclic heterocycle compounds useful as HIV integrase inhibitors2024